China Chinopharma Ltd

  • Home
  • About CSC
    • Introduction
    • Cooperation
  • News
    • Company News
    • Industry News
    • Picture News
    • Job Vacancy
  • Photo Album
    • Exhibition promotion
    • Visitors
    • Company style
  • Milestone
  • Advantage
    • Description
    • Registration Ability
    • Confidentiality Measures
    • Sales Ability
    • Storage
  • Contact Us
  • Product
    • Approved
    • Filed
    • API&Excipients
中文

Chinopharma Ltd

  • Description
  • Registration Ability
  • Confidentiality Measures
  • Sales Ability
  • Storage

34 IDL certificates:Been granted by NMPA from 2006 to 2017.
56 API products:Status "A" by Oct. of 2020.
41 API products:Status "I" by Oct. of 2020.
280 API products:To be filed.
52 products from India:Has been commercialized by end of 2018. 
275 products: Exclusive agency agreements signed with over 100 pharmaceutical manufacturers.
+700 FDF customers:CSC has good business relationship in China market.
Over 50 million US dollars:CSC’s annual sales volume in 2018.
Over 3300 products &1000 companies:CSC built its own data base.

 
 
 
Copyright © 2019. China Chinopharma Ltd. All rights reserved. 沪公网安备 31011202003736号 沪ICP备08008246号-1